b'Investment Stays Strong $ 1.2 BResilience During a Challenging Year RAISED IN for U.S. Life Sciences Financings FIRST HALF In 2023, early-stage funding in Colorado life sciences companies grew atOF 2024rates faster than most other markets in the country. Pre-Seed and Seed funding more than doubled to $29M up from $11M in 2022. Series A and B funding grew to $246M from $193M.$ 1.47 B IN 2023FEDERAL FUNDING$ 560.9 M PUBLIC CAPITALTOP 3 FEDERAL FUND RECIPIENTS: $ 499.2 M1. The University of Colorado System2. Colorado State University3. National Jewish HealthPRIVATE CAPITAL$ 402.8 MPRE-SEED/SEED SERIESA+B SERIESC,D+LATER$29.7M $246.6M$126.4M14 BIOSCIENCE COLORADO 2024-2025Source: Colorado BioScience Association'